Key Insights

Highlights

Success Rate

57% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

30.0%

3 terminated out of 10 trials

Success Rate

57.1%

-29.4% vs benchmark

Late-Stage Pipeline

40%

4 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

57% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (1)
P 1 (1)
P 3 (4)

Trial Status

Completed4
Terminated3
Recruiting1
Active Not Recruiting1
Withdrawn1

Trial Success Rate

57.1%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (10)

Research Network

Activity Timeline